October 14, 2008 – Medtronic released, at TCT 2008, new data from the ENDEAVOR clinical program that reinforces the ...
October 14, 2008 - CoreValve said the expanded clinical evaluation of its ReValving System for percutaneous aortic valve ...
The Philips cath lab experience provides interaction between image acquisition and visualization technologies, hemodynamic monitoring and charting, cath lab and statistical reporting and multimodality image access, viewing and storage.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 14, 2008 - St. Jude Medical Inc. said today at TCT 2008 that the FDA and European CE Mark approval of the Angio-Seal Evolution Vascular Closure Device.
October 14, 2008 - Edwards Lifesciences Corp. released new data from two studies of the Edwards SAPIEN transcatheter ...
October 13, 2008 - Boston Scientific Corp. released comprehensive data for the TAXUS ATLAS clinical program, a series of ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 13, 2008 – Piedmont Hospital in Atlanta, GA, is installing the Aquilion ONE from Toshiba America Medical Systems ...
October 13, 2008 - Of those treated with Medtronic’s Endeavor Resolute drug-eluting stent (DES) in the RESOLUTE IDE ...
October 13, 2008 – GE Healthcare is featuring real-time imaging solutions made possible, in part, by new collaborative partnerships, at TCT 2008 The GE Innova cardiovascular X-ray system will soon be aided by the new Innova Dose, Innova 3D and Innova with Stent Technologies features. GE’s Innova Dose package aims to deliver superb image quality and custom dose management.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 13, 2008 – At TCT 2008, Boston Scientific Corp. announced results from an analysis of nearly 7,500 patients from ...
October 12, 2008 – Research results indicate that optical coherence tomography (OCT) may be the best tool available to detect vulnerable plaque (VP) in coronary arteries, according to findings that will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
October 13, 2008 - GE Healthcare and Boston Scientific Corp. agreed to collaborate to improve intravascular ultrasound ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 10, 2008 - Boston Scientific Corp. today said it received FDA approval to market its second-generation TAXUS Liberte Paclitaxel-Eluting Coronary Stent System and the company plans to launch the stent early next month in the U.S.
October 10, 2008 - A recent study published in the October issue of Journal of Neuroimaging showed CT angiography (CTA) ...
October 10, 2008 - TeraRecon Inc. this weekend will release new innovations in its flagship Aquarius iNtuition platform ...